Evidence map›Paper›PMID 36138992›Full record

ArticleBrain sciences2022

Giant Non-Functioning Pituitary Adenomas: Treatment Considerations.

Domenico Solari, Luigi Maria Cavallo, Chiara Graziadio, Sergio Corvino, Ilaria Bove, Felice Esposito, Paolo Cappabianca

Open access · goldAbstract read
In one paragraph

Article in Brain sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Domenico SolariDivision of Neurosurgery, Università degli Studi di Napoli "Federico II", Via Pansini 5, 80131 Naples, Italy.ORCID 0000-0003-1535-8737
Luigi Maria CavalloDivision of Neurosurgery, Università degli Studi di Napoli "Federico II", Via Pansini 5, 80131 Naples, Italy.
Chiara GraziadioDivision of Endocrinology, Università degli Studi di Napoli "Federico II", Via Pansini 5, 80131 Naples, Italy.
Sergio CorvinoDivision of Neurosurgery, Università degli Studi di Napoli "Federico II", Via Pansini 5, 80131 Naples, Italy.ORCID 0000-0003-4918-6857
Ilaria BoveDivision of Neurosurgery, Università degli Studi di Napoli "Federico II", Via Pansini 5, 80131 Naples, Italy.
Felice EspositoDivision of Neurosurgery, Università degli Studi di Napoli "Federico II", Via Pansini 5, 80131 Naples, Italy.ORCID 0000-0003-1051-5924
Paolo CappabiancaDivision of Neurosurgery, Università degli Studi di Napoli "Federico II", Via Pansini 5, 80131 Naples, Italy.
University of Naples Federico II · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Giant pituitary adenomas are a subgroup of pituitary adenomas defined by a diameter greater than 4 cm, and they account for 5-14% of adenomas in surgical series. Because of their growth patterns and locations, often involving critical neurovascular structures, they represent a true surgical challenge, and gross total resection is difficult to achieve. There is no consensus on the optimal surgical strategy for giant pituitary adenomas, and, often, integrated multi-staged treatment strategies have been considered. Transcranial or transsphenoidal approaches, alone or combined, according to tumor and patient features are the two main routes. Each of these strategies has pros and cons. The conventional transcranial approach has for a long time been considered the first choice for the removal of giant pituitary adenomas. Currently, with endoscopic techniques, it is also possible to remove lesions that involve the intradural compartment and the adjacent neurovascular structures with the use of extended approaches. Our policy for the management of these lesions is to adopt the endoscopic endonasal approach as the first choice unless the tumor presents significant intracranial extension that results in it being outside the visibility and maneuverability of the endoscopic endonasal route. In these latter cases, we agree that the transcranial approach is more appropriate. However, accurate preoperative evaluation and refined treatment plans for each patient are mandatory to define a proper strategy in order to achieve the most effective long-term result.

Indexed as

endocrinologyendoscopic endonasal surgerygiant tumorsneurosurgerypituitary adenomaspituitary/hypothalamusskull base surgery

Identifiers

PMID36138992
PMCPMC9497296
OpenAlexW4296252944

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.